Author: Fiona Craig

  • Oriole Resources Reports Encouraging Gold Exploration Progress in Africa

    Oriole Resources Reports Encouraging Gold Exploration Progress in Africa

    Oriole Resources PLC (LSE:ORR) has released its interim results for H1 2025, highlighting substantial progress across its gold exploration projects in Cameroon and Senegal. The company completed its first drilling campaign at the Mbe project in Cameroon, uncovering promising gold mineralization, and is preparing an initial JORC Mineral Resource Estimate (MRE) for the MB01-S target.

    At the Bibemi project, Oriole updated its Mineral Resource Estimate and continued metallurgical testing to optimize gold recovery processes. In Senegal, the company is finalizing a joint venture to advance exploration at the Senala project.

    Financially, Oriole recorded a pre-tax loss of £0.57 million, reflecting higher administrative costs due to expanded operations in Cameroon. Despite this, management remains optimistic, supported by strong gold prices and positive exploration results.

    About Oriole Resources PLC

    Oriole Resources PLC is a gold exploration company listed on AIM, focused on projects in West and Central Africa. The firm specializes in the exploration and development of gold resources, with primary operations in Cameroon and Senegal.

    This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

  • Renalytix Anticipates Revenue Growth Through Tempus Collaboration

    Renalytix Anticipates Revenue Growth Through Tempus Collaboration

    Renalytix (LSE:RENX) has updated its revenue guidance, forecasting significant growth driven by its partnership with Tempus AI, Inc. The company expects revenues of $8.4 million in FY26, $19 million in FY27, and $42 million in FY28, reflecting the anticipated benefits of integrating its technology within hospital systems and healthcare providers.

    Despite these positive strategic developments, the company faces notable financial challenges, including declining revenues, high operating losses, and solvency concerns. While the collaboration with Tempus underscores growth potential, weak technical indicators and valuation pressures limit the stock’s attractiveness.

    About Renalytix

    Renalytix is an AI-enabled in vitro diagnostics company focused on improving clinical management of kidney disease. Its flagship product, kidneyintelX.dkd, is the only FDA-approved and Medicare-reimbursed prognostic test for early-stage risk assessment in chronic kidney disease, commercially available in the United States.

    This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

  • Raspberry Pi Reports Mixed H1 2025 Results Amid Strong Product Demand

    Raspberry Pi Reports Mixed H1 2025 Results Amid Strong Product Demand

    Raspberry Pi Holdings plc (LSE:RPI) has reported a mixed financial performance for the first half of 2025, with revenue down 6% and profit before tax falling 43% compared to the prior year. Despite these declines, direct sales of single-board computers and Compute Modules rose 21%, driven by strong demand from OEM customers.

    The company launched seven new products and reached a milestone as semiconductor unit volumes exceeded board unit volumes for the first time. Looking ahead, Raspberry Pi expects the second half of 2025 to deliver higher volumes supported by a strong order backlog, while maintaining full-year profit expectations.

    While strong revenue growth and operational stability support the outlook, high valuation and bearish technical indicators temper investor sentiment. Positive corporate developments provide some support, but ongoing attention to efficiency and cash flow management remains crucial.

    About Raspberry Pi Holdings plc

    Headquartered in Cambridge, UK, Raspberry Pi Holdings is a leader in low-cost, high-performance computing platforms. The company operates as a full-stack engineering organization, with expertise in semiconductor IP development, electronic design, and software engineering. Its products serve industrial, educational, and semiconductor markets, and the company is also known for its contributions to the Raspberry Pi Foundation, supporting computing education worldwide.

    This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

  • B.P. Marsh & Partners Reports Strong Trading and Strategic Investments

    B.P. Marsh & Partners Reports Strong Trading and Strategic Investments

    B.P. Marsh & Partners Plc (LSE:BPM) has reported robust trading results for the six months ending July 2025, marked by the completion of one disposal and five new investments. The company also maintained a healthy pipeline for potential deals and executed a successful share buy-back program. A secondary placing highlighted strong institutional demand, reinforcing confidence in the company’s long-term growth strategy.

    Strategic investments, including stakes in iO Finance Partners and Amiga Specialty, are well positioned to benefit from structural shifts in the UK SME finance market.

    The company’s outlook is underpinned by solid financial performance and an attractive valuation. Strong profitability, consistent growth, a low P/E ratio, and a solid dividend yield make B.P. Marsh & Partners an appealing investment. Technical indicators suggest a neutral to slightly bearish short-term trend, which slightly moderates the overall assessment.

    About B.P. Marsh & Partners Plc

    B.P. Marsh & Partners is a specialist venture capital investor focusing on early-stage financial services businesses. It invests in innovative companies across the financial services sector, particularly in niche areas underserved by traditional institutions, aiming to support strong growth potential and long-term value creation.

    This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

  • Oxford BioMedica Delivers Strong H1 2025 Results, Reinforcing Market Leadership

    Oxford BioMedica Delivers Strong H1 2025 Results, Reinforcing Market Leadership

    Oxford BioMedica (LSE:OXB) has reported robust financial results for the first half of 2025, with revenues rising 44% to £73.2 million, driven by strong demand for its CDMO services. The company improved profitability, reducing its operating EBITDA loss, and strengthened its balance sheet through new financial facilities and share placements.

    Strategic initiatives, including the expansion of US commercial-scale GMP capacity, are expected to support continued growth and further enhance Oxford BioMedica’s market position.

    The company’s outlook is supported by positive earnings call insights and key corporate developments, signaling strategic growth and management confidence. Nevertheless, financial performance pressures and valuation considerations moderate the overall assessment.

    About Oxford BioMedica

    Oxford BioMedica is a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapies. The company provides services across various vector types, focusing on late-stage and commercial programs, and is recognized for its innovation and high-quality manufacturing, establishing it as a leader in the cell and gene therapy sector.

    This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

  • Smiths Group Reports Strong FY2025 Performance, Surpassing Growth Targets

    Smiths Group Reports Strong FY2025 Performance, Surpassing Growth Targets

    Smiths Group plc (LSE:SMIN) has announced robust financial results for the fiscal year ending 31 July 2025, with organic revenue up 8.9% and operating profit margin rising to 17.4%. The company exceeded its growth guidance despite challenging macroeconomic conditions and a difficult US construction market.

    Strategic initiatives, including the separation of Smiths Interconnect and targeted acquisitions, are progressing successfully, positioning Smiths as a high-performance industrial engineering business. Management remains confident about FY2026, anticipating continued revenue growth and further margin expansion.

    The company’s strong financial results and strategic actions, such as share buybacks, support a positive outlook, although a high P/E ratio indicates a relatively premium valuation, tempering the overall assessment slightly.

    About Smiths Group plc

    Smiths Group is an industrial engineering company focused on addressing critical global challenges, including decarbonization and energy efficiency. The company delivers mission-critical products and services to clients in the energy, construction, and industrial sectors, leveraging deep engineering expertise and practical experience.

    This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

  • Kooth Reports Strong H1 2025 User Growth and Strategic Expansion

    Kooth Reports Strong H1 2025 User Growth and Strategic Expansion

    Kooth PLC (LSE:KOO) has released its unaudited half-year results for 2025, highlighting notable growth in its user base and targeted investments, particularly across the US market. While reported revenue saw a slight decline due to currency fluctuations, the company has made significant inroads in California and New Jersey, with more than 130,000 users registered on its Soluna platform.

    Kooth maintains a strong cash position and a clear strategic focus on broadening its service offerings, positioning the company for sustainable growth. Favorable policy developments in both the US and UK—emphasizing early intervention and digital access—support the increasing demand for digital mental health solutions.

    About Kooth PLC

    Kooth is a leading provider of digital mental health services, delivering safe, accessible platforms for therapeutic support and interventions. The company emphasizes early intervention and prevention and is the largest single-access provider for mental health support for under-18s in the UK. Kooth has recently expanded its operations into the US in response to rising demand for youth mental health services.

    This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

  • ZIGUP Reports Strong Start to FY26 and Key Strategic Developments

    ZIGUP Reports Strong Start to FY26 and Key Strategic Developments

    ZIGUP plc (LSE:ZIG) has kicked off the financial year with performance surpassing last year, supported by steady vehicle supply aiding fleet replacement programs. The company has renewed contracts with existing insurance clients and is preparing to launch services in partnership with a major new insurance broker.

    In addition, ZIGUP has introduced a new Operations Control Centre and upgraded its UK call-centre infrastructure, improving operational efficiency and service delivery. Management remains confident in the company’s long-term growth strategy, maintaining a stable financial outlook and planning a final dividend of 17.6 pence per share. The recently published FY2025 Sustainability Progress Report underlines the company’s ongoing commitment to sustainable growth.

    While the outlook is moderated by financial performance challenges, including lower revenue and weaker cash flow, the company’s attractive valuation, low P/E ratio, and high dividend yield provide support. Technical analysis points to bearish momentum, but these factors balance the overall assessment.

    About ZIGUP plc

    ZIGUP is a leading provider of integrated mobility solutions, offering services across the full vehicle lifecycle. Its platform serves businesses, fleet operators, insurers, OEMs, and other clients, covering areas such as vehicle rental, fleet management, accident management, and vehicle repair. ZIGUP is also recognized for promoting social mobility and guiding customers toward more connected and lower-carbon mobility solutions.

    This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

  • GB Group Announces Main Market Move and Confirms Positive Trading

    GB Group Announces Main Market Move and Confirms Positive Trading

    GB Group plc (LSE:GBG) has revealed plans to transfer its listing from AIM to the Main Market of the London Stock Exchange, with the transition expected on 30 October 2025, subject to regulatory approval. The move is designed to strengthen the company’s market profile and provide greater operational flexibility.

    Alongside this, GBG confirmed that current trading aligns with board expectations, and management remains confident in achieving full-year revenue targets.

    The company’s outlook is underpinned by strong financial performance, particularly in cash flow and profitability. Technical indicators show moderate bullish momentum, although valuation considerations, including a high P/E ratio, temper the overall score. The lack of recent earnings calls or significant corporate events does not impact the outlook.

    About GB Group plc

    GB Group plc (GBG) is a global identity technology company enabling secure and efficient digital interactions. Leveraging more than 30 years of expertise, GBG combines global data with innovative technology to help individuals verify identity and location online. The company supports businesses in preventing digital fraud, strengthening operational resilience, and promoting responsible growth. GBG serves over 20,000 customers worldwide and employs more than 1,100 people.

    This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

  • Fonix Mobile Reports Solid FY25 Results and Strategic Growth Initiatives

    Fonix Mobile Reports Solid FY25 Results and Strategic Growth Initiatives

    Fonix Mobile PLC (LSE:FNX) has posted strong results for the fiscal year ending 30 June 2025, with gross profit rising 3.9% and adjusted EBITDA increasing 6.6%. The company has broadened its international presence, with overseas markets now accounting for 13% of gross profit, and introduced new products such as PayFlex and CompsPortal to enhance multi-channel payments and interactivity.

    Looking ahead, Fonix expects FY26 growth to be driven by international expansion and continued product innovation, diversifying revenue streams and strengthening its leadership in interactive services.

    The company benefits from solid financial performance, consistent profitability, and low financial risk. Its strategic expansion and diversified product portfolio are positive indicators for future growth. While technical signals are mixed, the stock’s fair valuation and appealing dividend yield add to its attractiveness. Overall, Fonix remains well-positioned in the mobile payments and interactive services market.

    About Fonix Mobile PLC

    Founded in 2006 and based in London, Fonix Mobile provides mobile payment and messaging solutions for businesses across media, charity, entertainment, and enterprise sectors. The company enables seamless consumer engagement and transactions, working with leading clients including ITV, Bauer Media, and BBC Children in Need. Fonix emphasizes technology and user experience to drive the evolution of mobile payments and interactivity.

    This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.